Immix Biopharma (IMMX) Free Cash Flow (2021 - 2026)

Quarterly results put Free Cash Flow at -$9.9 million for Q1 2026, down 462.49% from a year ago — trailing twelve months through Mar 2026 was -$32.8 million (down 144.61% YoY), and the annual figure for FY2025 was -$24.7 million, down 56.37%.

Immix Biopharma has reported Free Cash Flow over the past 6 years, most recently at -$9.9 million for Q1 2026.

  • Free Cash Flow reached -$9.9 million in Q1 2026 per IMMX's latest filing, up from -$11.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$547066.0 in Q2 2022 and bottomed at -$11.2 million in Q4 2025.
  • Median Free Cash Flow over the past 5 years was -$3.5 million (2023), compared with a mean of -$4.1 million.
  • The largest annual shift saw Free Cash Flow plummeted 2781.24% in 2022 before it skyrocketed 57.55% in 2025.
  • Over 5 years, Free Cash Flow stood at -$3.9 million in 2022, then skyrocketed by 31.08% to -$2.7 million in 2023, then rose by 26.29% to -$2.0 million in 2024, then tumbled by 464.44% to -$11.2 million in 2025, then grew by 11.93% to -$9.9 million in 2026.
  • Business Quant data shows Free Cash Flow for IMMX at -$9.9 million in Q1 2026, -$11.2 million in Q4 2025, and -$6.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.29 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 848.30 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 48.67 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - -9.86 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -9.86 Mn
Mar 31, 2026 -9.86 Mn
Dec 31, 2025 -11.19 Mn
Dec 31, 2025 -11.19 Mn
Sep 30, 2025 -6.28 Mn
Sep 30, 2025 -6.28 Mn
Jun 30, 2025 -5.44 Mn
Jun 30, 2025 -5.44 Mn
Mar 31, 2025 -1.75 Mn
Mar 31, 2025 -1.75 Mn
Dec 31, 2024 -1.98 Mn
Dec 31, 2024 -1.98 Mn
Sep 30, 2024 -4.31 Mn
Sep 30, 2024 -4.31 Mn
Jun 30, 2024 -5.35 Mn
Jun 30, 2024 -5.35 Mn
Mar 31, 2024 -4.13 Mn
Mar 31, 2024 -4.13 Mn
Dec 31, 2023 -2.69 Mn
Dec 31, 2023 -2.69 Mn
Sep 30, 2023 -3.09 Mn
Sep 30, 2023 -3.09 Mn
Jun 30, 2023 -3.52 Mn
Jun 30, 2023 -3.52 Mn
Mar 31, 2023 -2.09 Mn
Mar 31, 2023 -2.09 Mn
Dec 31, 2022 -3.90 Mn
Dec 31, 2022 -3.90 Mn
Sep 30, 2022 -1.46 Mn
Sep 30, 2022 -1.46 Mn
Jun 30, 2022 -547,066.00
Jun 30, 2022 -547,066.00
Mar 31, 2022 -1.49 Mn
Mar 31, 2022 -1.49 Mn
Dec 31, 2021 -1.11 Mn
Dec 31, 2021 -1.11 Mn
Sep 30, 2021 -50,759.00
Sep 30, 2021 -50,759.00
Jun 30, 2021 -158,008.00
Jun 30, 2021 -158,008.00
Mar 31, 2021 -267,248.00
Mar 31, 2021 -267,248.00